BTG Share PerformanceMore

52 week high739.5 12/07/16
52 week low555.0 04/02/16
52 week change -50.5 (-8.19%)
4 week volume14,792,466 09/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

BTG's PneumRx Coils included in new guidelines

BTG has announced the inclusion of treatment with PneumRx Coils in guidelines for the management of chronic obstruc...

PneumRx GOLD

RNS Number: 8933Q BTG PLC 05 December 2016 PneumRx Coils included in new global clinical guidelines and given positive recommendation to treat severe emphysema patients in France London, UK, 5 December 2016: BTG plc (LSE: BTG), the global specialist healthcare company, today announces the inclusion of treatment with PneumRx Coils in guidelines for t...

Total Voting Rights

RNS Number: 7289Q BTG PLC 01 December 2016 1 December 2016 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 1 December 2016: 1. the Company's issued share capital consists of 385,088,997 Ordinaryshares of 10p each admitted to trading, and each with o...

Holding(s) in Company

RNS Number: 2249Q BTG PLC 25 November 2016 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG plc 2 Reason for the notification (please tick the appropriate b...

Broker Forecast - Deutsche Bank issues a broker note on BTG PLC

Deutsche Bank today reaffirms its buy investment rating on BTG PLC (LON:BTG) and cut its price target to 800p (from 8...

10 stocks for a truly 'all-weather' portfolio

Diversification is crucial - it's why Stockopedia's Ben Hobson has gathered the best quality and momentum stocks from 10 ...

Broker Forecast - JP Morgan Cazenove issues a broker note on BTG PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on BTG PLC (LON:BTG) and cut its price target to 800...

BTG has strong first half

BTG reports a strong first half performance with double-digit revenue growth. Revenues rose to 285.4m in the six months ...

Fundamental DataMore

P/E ratio35.823
Dividend yield0 %

Equity Research (BTG)

edison investment research
BTG plc
Growth across all three divisions of BTG’s Interventional Medicine (IM) franchise (oncology, vascular and pulmonology), coupled with currency tailwinds, helped push FY16 revenue towards the upper end...
edison investment research
BTG plc
BTG’s interim results have driven upgrades to our financial forecasts with a small boost to revenues from one-off Zytiga backdated royalties. Our operating expenses are broadly unchanged, but...
edison investment research
BTG plc
BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of £410-440m (at $1.61/£). This is based on slower-than-expected Varithena sales, despite a...

Latest discussion posts More

  • BTG announce gold standard for PneumRx? Coils

    Being a gold standard product should help BTG sell it sell it ,how ever ,knowing how B.T.G has moved in the past when marketing products word wide in the past then I'm not ...
    d gaser
  • Re: shorts on BTG

    Back in with a long position. This one is a trading dream. Couldn't agree more with UP., this is not the price to sell at. Growth story still intact. M
    sound money
  • PneumRX

    Todays RNS is great news & progress in France will hopefully be replicated elsewhere.Not sure what impact,if any ,it will have on our SP.

Users' HoldingsMore

Users who hold BTG also hold..

Codes & Symbols